A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

NCT06899217 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Gastroparesis

Interventions

DRUG: CIN-102 Dose 15mg
DRUG: Placebo
DRUG: CIN-102 Dose 10mg

Sponsor

CinDome Pharma, Inc.